ICU sedation, delirium & recovery
Outcomes of critically ill patients with newly diagnosed Burkitt’s lymphoma: a monocentric retrospective study
Authors' conclusion
Despite low severity scores at admission, short-term and long-term survival remain poor, with half of patients dying within one year. However, among one-year survivors, nearly all achieved complete remission with good functional outcomes. TLS, vasopressor use, HIV infection, male sex, and increasing age were independently associated with one-year mortality.
Study context
- Population
- Critically ill patients admitted to the intensive care unit (ICU) of Saint-Louis Hospital with newly diagnosed Burkitt's lymphoma, 2002–2023
- Participants
- 124 patients
- Outcome
- Mortality and factors associated with mortality
- Follow-up
- 3 months and 12 months
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
Mortality
90-day mortality
34%
42/124
1-year mortality
50%
60/119
Observational data: associations, not effects.
Further findings
Outcomes among 1-year survivors
- Complete remission
- 98% (59/60)
- Good functional outcome (performance status 0 or 1)
- 90% (52/58)
Patient characteristics and ICU course
- Median age, years
- 47.5 (IQR, 34-58.5)
- HIV infection
- 60% (74/124)
- Chemotherapy during ICU stay
- 84% (104/124)
- Developed tumor lysis syndrome (TLS)
- 59% (73/124)
Original publication
Outcomes of critically ill patients with newly diagnosed Burkitt’s lymphoma: a monocentric retrospective study. Ann Intensive Care. Published 22 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →